Search Result For: oral wegovy

Date: 2025/06/02 - 00:00

What Is ‘Skinny Tok?’ Experts Debunk the Harmful TikTok Trend for Weight Loss

"Skinny Tok" is an extreme dieting trend on TikTok that equates thinness with health. Experts warn the trend perpetuates negative body image and harmful diet culture, as extreme calorie restriction has mental and physical consequences.

Date: 2025/05/29 - 22:30

NIH scientists pioneer promising treatment for intractable cancer pain

RTX is a non-addictive pain therapy derived from a cactus-like plant.

A person holding a tray full of test tubes of blood to be sent off for Alzheimer's diagnosis

Date: 2025/05/22 - 21:00

First blood test for Alzheimer's gets FDA greenlight: 3 things to know

The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and beta-amyloid 1-42 in plasma.

middle-aged white woman pictured in half-shadow

Date: 2025/05/21 - 20:00

Why do some people get dementia in middle age?

Protein changes linked to RNA regulation and brain connectivity could help explain how frontotemporal dementia develops in middle age.

Date: 2025/05/20 - 19:31

Replacing 30 minutes' sitting time with exercise may prevent second heart attack

A secondary heart attack could be prevented by replacing 30 minutes of sedentary behavior with light-intensity or moderate-to-vigorous-intensity physical activity, or even with sleep.

Date: 2025/05/19 - 22:32

Zepbound More Effective for Weight Loss Than Wegovy, Eli Lilly Trial Shows

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk factors. Tirzepatide's dual effects on GLP-1 and GIP may explain its superior performance.

A person holding an Ozempic pen, the active ingredient of which is semaglutide

Date: 2025/05/18 - 16:31

Semaglutide may reduce heart disease risk, even within first 6 months

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular events after just six months of starting the medication, a new study indicates.

Date: 2025/05/15 - 23:32

FDA Accepts Novo Nordisk’s Application for Oral Wegovy: 5 Things to Know

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss medication Wegovy. Experts say an oral medication for weight loss might be more cost effective and easier for people to use.

Dozens of analog alarm clocks piled on top of each other

Date: 2025/05/15 - 19:00

8-hour time-restricted eating may be key to long-term weight loss, trial finds

Three months of 8-hour time-restricted eating (TRE), regardless of the time of the day, helped sustain long-term weight loss in adults with overweight or obesity, preliminary results from a clinical trial has shown.

Date: 2025/05/13 - 23:32

First-Generation GLP-1 Drugs May Help Lower Risk of Obesity-Related Cancers

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide, exenatide, and dulaglutide were 41% more effective at preventing obesity-related cancers.